Palatin Technologies

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTN and other ETFs, options, and stocks.

About PTN

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). 

CEO
Carl Spana
CEOCarl Spana
Employees
33
Employees33
Headquarters
Cranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded
1986
Founded1986
Employees
33
Employees33

PTN Key Statistics

Market cap
45.95M
Market cap45.95M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
33.80K
Average volume33.80K
High today
$4.24
High today$4.24
Low today
$4.12
Low today$4.12
Open price
$4.24
Open price$4.24
Volume
8.78K
Volume8.78K
52 Week high
$24.00
52 Week high$24.00
52 Week low
$3.99
52 Week low$3.99

PTN Earnings

-$1.50
-$1.17
-$0.83
-$0.50
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
-$1.19 per share
Estimated-$1.19 per share
Actual
-$0.86 per share
Actual-$0.86 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.